Skip to main content

Table 2 Multivariable analysis revealed that the pre-operative CRP-level is an independent prognostic marker for cancer- specific survival

From: Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients

Variable P value HR (95%CI)
Age [years] 1 <0.001 1.03 (1.01-1.04)
Sex 0.74  
female   1
male   0.96 (0.72-1.26)
T stage 0.07  
pT1a   1
pT1b 0.74 1.08 (0.69-1.69)
pT2 0.34 1.30 (0.76-2.22)
pT3a 0.006 1.90 (1.20-2.99)
pT3b 0.20 1.35 (0.86-2.13)
pT3c 0.35 2.00 (0.46-8.59)
pT4 0.89 0.94 (0.42-2.20)
LN metastases 2 <0.001  
N-   1
N+   3.59 (2.46-5.25)
Pulmonary or visceral metastases 2 <0.001  
M-   1
M+   3.23 (2.31-4.50)
Differentiation 0.02  
G1   1
G2 0.01 1.97 (1.16-3.34)
G3 0.003 2.47 (1.36-4.51)
G4 0.01 4.13 (1.38-12.34)
Histological subtype 0.17  
non ccRCC   1
ccRCC   1.43 (0.85-2.41)
CRP-value 2 <0.001  
<4 mg/l   1
4-10 mg/l 0.03 1.66 (1.06-2.59)
>10 mg/l <0.001 2.58 (1.83-3.64)
  1. 1continuous metric variable, 2 at the time of surgery.